Publication: FTY720 restores endothelial cell permeability induced by malaria sera
Issued Date
2018-12-01
Resource Type
ISSN
20452322
Other identifier(s)
2-s2.0-85050638110
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific Reports. Vol.8, No.1 (2018)
Suggested Citation
Karanyaporn Oggungwan, Supattra Glaharn, Sumate Ampawong, Srivicha Krudsood, Parnpen Viriyavejakul FTY720 restores endothelial cell permeability induced by malaria sera. Scientific Reports. Vol.8, No.1 (2018). doi:10.1038/s41598-018-28536-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/47460
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
FTY720 restores endothelial cell permeability induced by malaria sera
Other Contributor(s)
Abstract
© 2018, The Author(s). Increased endothelial cell (EC) permeability in severe Plasmodium falciparum malaria contributes to major complications of severe malaria. This study explored EC permeability in malaria, and evaluated the potential use of FTY720 to restore EC permeability. ECs were incubated with sera from malaria patients (P. vivax, uncomplicated and complicated P. falciparum malaria). Cellular permeability was investigated using a fluorescein isothiocyanate (FITC)-dextran permeability assay. FTY720, an analogue of sphingosine-1-phosphate (S1P), was tested for its potential action in maintaining EC integrity. ECs incubated with sera from malaria patients with complicated P. falciparum showed higher fluorescein leakage compared with ECs incubated with sera from P. vivax (p < 0.001) and uncomplicated P. falciparum (p < 0.001). ECs pretreated with FTY720 before incubation with malaria sera had significantly decreased fluorescein leakage compared with no FTY720 treatment. In addition, FTY720 treatment significantly reduced fluorescein leakage for both uncomplicated (at 45 min) (p = 0.015), and complicated P. falciparum malaria (15 min) (p = 0.043). The permeability increase induced by complicated P. falciparum sera was significantly reversed and prevented by FTY720 in vitro. FTY720 may have clinical applications to protect against endothelial barrier dysfunction in severe P. falciparum malaria.